10monon MSN
Moderna said a new version of its Covid vaccine triggered a stronger immune response against the virus than its current shot ...
Data on mRNA vaccines sent by Moderna to European regulators before the COVID-19 outbreak included early tests of the mRNA ...
Moderna says it has become the first company in the pharma sector with phase 3 data on a combined vaccine for both COVID-19 and influenza and will soon be ready to discuss “next steps” with ...
Moderna's mRNA technology gained rapid validation as sales of its covid vaccine soared in 2021 ... The convenience of a combination shot could draw some of the 150 million Americans who receive ...
(Reuters) -Moderna cut its 2025 sales forecast by $1 billion on Monday, hurt by a slow adoption of its respiratory syncytial virus (RSV) shot and weak demand for COVID-19 vaccines, sending its ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results